Literature DB >> 28138648

Report of one case: surgical treatment for neuroendocrine tumors.

Hanjie Hu1, Hong Zhao1.   

Abstract

A 68-year-old female patient was admitted to our center due to anorexia and epigastric pain for 2 months. Plain abdominal CT revealed a splenic space-occupying lesion; it had invaded the greater curvature of stomach and had blurred margin with the tail of pancreas. The longest diameter was about 10.7 cm. The lesion was considered to be malignant, accompanied with peritoneal nodules; the possibility of lymph node metastasis could not be ruled out. MRI revealed that the mass was located in front of the spleen, with irregular shape and unclear margin. Part of the mass invaded the greater curvature of stomach and part of it had blurred margin with the tail of pancreas. The largest cross section sized 9.4 cm × 6.9 cm. It showed intermediate and high signals on T2WI/FS, which corresponded to restricted diffusion on DWI sequences. The levels of tumor markers including CA19-9, CA242, and CEA were normal. Exploratory laparotomy + resection of the body and tail of pancreas + resection of part of stomach wall + removal of nodules on liver surface were performed. Postoperative pathology confirmed that the lesion was a neuroendocrine tumor (G1).

Entities:  

Keywords:  Neuroendocrine tumors; surgical treatment

Year:  2016        PMID: 28138648      PMCID: PMC5244635          DOI: 10.21037/tgh.2016.10.05

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  3 in total

1.  Neuroendocrine hepatic metastases: does aggressive management improve survival?

Authors:  John G Touzios; James M Kiely; Susan C Pitt; William S Rilling; Edward J Quebbeman; Stuart D Wilson; Henry A Pitt
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

2.  Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience.

Authors:  Jean-Marc Guettier; Anthony Kam; Richard Chang; Monica C Skarulis; Craig Cochran; H Richard Alexander; Steven K Libutti; James F Pingpank; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

3.  Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.

Authors:  Michael G House; John L Cameron; Keith D Lillemoe; Richard D Schulick; Michael A Choti; Donna E Hansel; Ralph H Hruban; Anirban Maitra; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-01       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.